Policy & Medicine - Legal, Regulatory, and Compliance Issues

In today's highly regulated healthcare environment, commercial compliance has become among the most pressing topics on…

GlaxoSmithKline’s 2012 Corporate Integrity Agreement made mandatory the company’s “Patient First” program (or a…

Thomas Stossel, American Cancer Society Professor of Medicine at Harvard Medical School and a visiting scholar at the American…

The Food and Drug Administration last week finalized two guidances intended to speed the process of getting innovative…

A recent article published in Forbes argues that online medical education has the opportunity to revolutionize training…

To comply with the Physician Payments Sunshine Act, drug and medical device manufacturers submitted their 2014 Open Payments…

This month we are launching  our newest publication, Life Science Compliance Update.  This publication promises to deliver…

 The House Ways and Means Subcommittee on Oversight recently held a hearing on the federal government’s use of data analysis to…

Last week we posted a comprehensive look at the increased scrutiny into laboratories that engage in referrals with…

Arnold & Porter is hosting a full-day, interactive program aimed at providing industry professionals with unique real world…